✦ LIBER ✦

Pramipexole warning on sudden onset of sleep

Book ID: 120871959
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 1999
Weight: 190 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-199911990-00044

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ropinirole: sudden onset of sleep warnin

Ropinirole: sudden onset of sleep warning issued in Canada

📂 Article 📅 2000 🏛 Adis International Limited (now part of Wolters Kl ⚖ 136 KB

Sudden onset of cervical myelopathy duri

Sudden onset of cervical myelopathy during sleep

✍ Ball, Alex K.; Haboubi, Naseer H. 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Dopamine agonists: sudden onset of sleep

Dopamine agonists: sudden onset of sleep is infrequent

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Predictors of sudden onset of sleep in P

Predictors of sudden onset of sleep in Parkinson's disease

✍ Yvonne Körner; Charlotte Meindorfner; Jens Carsten Möller; Karin Stiasny-Kolster 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 268 KB 👁 1 views

## Abstract With respect to the ongoing discussion of “sleep attacks” in Parkinson's disease (PD), we sought to estimate the prevalence of sudden onset of sleep (SOS) with and without preceding sleepiness in PD, to identify associated factors, and to define the role of antiparkinsonian medication i

Sudden onset of cervical spondylotic mye

Sudden onset of cervical spondylotic myelopathy during sleep: A case report

✍ Irene A. Young; Stephen P. Burns; James W. Little 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Impact of pramipexole on the onset of le

Impact of pramipexole on the onset of levodopa-related dyskinesias

✍ Radu Constantinescu; Megan Romer; Michael P. McDermott; Cornelia Kamp; Karl Kieb 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

## Abstract Dyskinesias are a major complication of dopaminergic therapy in the long‐term treatment of Parkinson's disease. In the CALM‐PD trial, subjects were initially randomized to levodopa or pramipexole and could later add levodopa if needed. After adjusting for disease duration and daily levo